These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10688237)

  • 1. Partnering with nurses to manage heparin therapy with a weight-based protocol.
    Price CK; Colodny L
    Am J Health Syst Pharm; 2000 Jan; 57(2):110-2, 115-6. PubMed ID: 10688237
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal weight base for a weight-based heparin dosing protocol.
    Yee WP; Norton LL
    Am J Health Syst Pharm; 1998 Jan; 55(2):159-62. PubMed ID: 9465981
    [No Abstract]   [Full Text] [Related]  

  • 3. Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program.
    Wellman JC; Kraus PS; Burton BL; Ensor CR; Nesbit TW; Ross PA; Thomas ML; Streiff MB
    Am J Health Syst Pharm; 2011 May; 68(10):934-9. PubMed ID: 21546645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticoagulant therapy with i.v. non-fractionated sodium heparin with normogram based on body weight: evaluation of a series of 50 patients with venous thromboembolic disease].
    Landini G; Mugnaini C; Cosmi I; Cini S; Colacoci S; Pennati P; Rosselli A; Ghetti A
    Minerva Cardioangiol; 1998 Oct; 46(10):378-80. PubMed ID: 10021817
    [No Abstract]   [Full Text] [Related]  

  • 5. A pharmacist-managed anticoagulation clinic: six-year assessment of patient outcomes.
    Willey ML; Chagan L; Sisca TS; Chapple KJ; Callahan AK; Crain JL; Kitenko LE; Martin T; Spedden KD
    Am J Health Syst Pharm; 2003 May; 60(10):1033-7. PubMed ID: 12789876
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical considerations of heparinization.
    Cushinotto NM
    J Am Acad Nurse Pract; 1997 Jun; 9(6):273-6. PubMed ID: 9274247
    [No Abstract]   [Full Text] [Related]  

  • 7. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 8. A patient profile system for monitoring long-term anticoagulant therapy.
    Bernstein D; Harrison EC; McCarron MM
    Am J Hosp Pharm; 1974 Mar; 31(3):258-61. PubMed ID: 4819439
    [No Abstract]   [Full Text] [Related]  

  • 9. Achievement of anticoagulation by using a weight-based heparin dosing protocol for obese and nonobese patients.
    Spruill WJ; Wade WE; Huckaby WG; Leslie RB
    Am J Health Syst Pharm; 2001 Nov; 58(22):2143-6. PubMed ID: 11760916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a computerized system for intravenous heparin administration: using information technology to improve patient care and patient safety.
    Oyen LJ; Nishimura RA; Ou NN; Armon JJ; Zhou M
    Am Heart Hosp J; 2005; 3(2):75-81. PubMed ID: 15860993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a pharmacist-driven protocol for automatic medication dosage adjustments in obese patients.
    Russell JM; Nick-Dart RL; Nornhold BD
    Am J Health Syst Pharm; 2015 Oct; 72(19):1656-63. PubMed ID: 26386107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an Unfractionated Heparin Pharmacy Dosing Protocol for the Treatment of Venous Thromboembolism in Nonobese, Obese, and Severely Obese Patients.
    Hosch LM; Breedlove EY; Scono LE; Knoderer CA
    Ann Pharmacother; 2017 Sep; 51(9):768-773. PubMed ID: 28511582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol.
    Saya FG; Coleman LT; Martinoff JT
    Am J Hosp Pharm; 1985 Sep; 42(9):1965-9. PubMed ID: 4050813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.
    Myzienski AE; Lutz MF; Smythe MA
    Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I'm still here: reflections on 39 years of clinical practice in a community hospital-based anticoagulation service.
    Sisca TS
    Pharmacotherapy; 2011 Dec; 31(12):1156-60. PubMed ID: 22122178
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital readmissions.
    Lee YP; Schommer JC
    Am J Health Syst Pharm; 1996 Jul; 53(13):1580-3. PubMed ID: 8809280
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of heparin dosing based on adjusted body weight in obese patients.
    Fan J; John B; Tesdal E
    Am J Health Syst Pharm; 2016 Oct; 73(19):1512-22. PubMed ID: 27646813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight-adjusted and activated clotting time-guided heparinization might reduce the postprocedural hemorrhage in percutaneous transluminal angioplasty for acute middle cerebral artery occlusion.
    Li AH; Chan L; Chu YT; Chiu KM; Chu SH
    Stroke; 2004 Apr; 35(4):e77-8; author reply e77-8. PubMed ID: 14988565
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
    Brown A
    Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).
    Koracevic G
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):198-9. PubMed ID: 20118712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.